- Home
- Collections
- Congress on Demand 2021: Top Ten
Congress on Demand 2021: Top Ten
What did our delegates enjoy most at the 2021 BSAVA virtual Congress? For the busy practitioner we have created a collection of top ten highlights from congress; these lectures were our most popular during the live event. This collection can be purchased as a standalone item, with a discount for BSAVA members. Visit our Congress on Demand information page for information about how to access the rest of our 2021 congress lectures.
Collection Contents
2 results
-
-
Take a deep breath: BOAS surgery doesn’t have to be scary
BSAVA Congress Proceedings 2021Authors: Jane Ladlow and Rob WhiteNose and soft palate: In various studies, about 60% of dogs with BOAS had stenotic nares and 90% had an elongated palate. Using advanced imaging, the palate is not only long but also thickened (hyperplastic) which may be a secondary change to other areas of airway obstruction. The lesions sites are also breed specific, with nasal stenosis being more of an issue in French bulldogs and pugs than bulldogs where the hyperplastic palate is the most noticeable lesion. In an objective study of airway function the nostril status was the most significant conformational factor associated with BOAS (though we still see unaffected dogs with severely stenotic nostrils). As lesion sites vary between breeds and also between individuals of the same breed it is important to assess individuals carefully prior to surgery with a functional assessment (https://www.thekennelclub.org.uk/health-and-dog-care/health/getting-started-with-health-testing-and-screening/respiratory-function-grading-scheme/). We use a nasal grading scheme which is breed specific to assess the nostrils. Open and mildly affected nostrils are desirable (https://www.vet.cam.ac.uk/boas/about-boas/recognition-diagnosis#stenoticnares). There are a myriad of techniques described for soft palate resection and nasoplasty. This presentation covers the current surgical options for nasoplasty and soft palate resection, including alar fold resection and folding flap staphylectomy techniques along with the evidence behind them. Potential complications and outcomes (where known) are also discussed.
Laryngeal collapse and tracheostomy: Laryngeal collapse is a form of upper-airway obstruction caused by loss of cartilage rigidity that allows medial deviation of the rostral laryngeal cartilages. Although laryngeal collapse has usually been considered to be associated with progression of the BOAS, when it comes to the more advanced stages of the condition, the breed of dog is often indicative of the severity in laryngeal changes seen. Conventionally, the condition is sub-divided into three stages in the dog: in stage I laryngeal collapse there is eversion of the laryngeal saccules, in stage II there is loss of rigidity and medial displacement of the cuneiform processes of the arytenoid cartilage, and in stage III there is collapse of the corniculate processes of the arytenoid cartilages with loss of the dorsal arch of the rima glottidis. In its advanced forms, the condition is life-threatening and often very difficult to treat effectively. This presentation covers the condition and its potential management options (e.g. husbandry changes, surgical correction of primary abnormalities, sacculectomy, arytenoidectomy, cricoarytenoid and thyroarytenoid caudo-lateralisation, and permanent tracheostomy), highlighting the controversies and difficulties in its treatment.
-
-
-
Treatment of canine atopic dermatitis in 2021 – what options, in what order?
BSAVA Congress Proceedings 2021Authors: Tim Nuttall and Ariane Neuber-WattsOptions: Atopic dermatitis is a very common condition that severely compromises quality of life for affected dogs and their owners. It is a lifelong disease that requires ongoing treatment to maintain remission and prevent flares. Atopic dermatitis is a complex disease that involves a poor skin barrier, abnormal skin inflammation, allergies (in most but not all dogs) to environmental and/or food allergens, and secondary skin and ear infections. It is important to identify the triggers for each dog and then use a multimodal treatment programme to address these. Treatment options include topical emollients, essential fatty acid (EFA) supplements or enriched diets, palmitoylethanolamide (PEA), allergen specific immunotherapy (ASIT), antihistamines, and anti-inflammatory medication. Anti-inflammatory treatments with good evidence of high efficacy include systemic and topical steroids, ciclosporin, oclacitinib and lokivetmab. It is essential that these treatment options are understood so that they can be used effectively in the management of canine atopic dermatitis.
Strategy: Canine atopic dermatitis is a common skin disease in dogs. Affected patients and their owners can have severely reduced quality of life. Different treatment modalities need to be combined strategically for each patient to formulate a treatment plan that suits the given patient and carer. This may involve treatment of flare factors, symptomatic anti-pruritic therapy, immunotherapy and treatments to strengthen the skin barrier function. Optimal therapy depends on the patient, breed, temperament, body areas affected, severity of the skin disease, financial considerations and owner attitude and ability all come in the equation. Different scenarios are discussed in this presentation.
-